The characteristics of these molecular subtypes are largely distinguished by expression of various combinations of tumour markers such as oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2) and Ki67 tumour proliferation marker. This evidence concerns the gene PGR and neoplasm.